ClinicalTrials.gov
ClinicalTrials.gov Menu

TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00115050
Recruitment Status : Completed
First Posted : June 21, 2005
Last Update Posted : June 10, 2011
Sponsor:
Information provided by:
Tibotec Pharmaceuticals, Ireland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2007
  Actual Study Completion Date : June 2007
  Certification/Extension First Submitted : June 2, 2011